live attenuated yellow fever virus strain 17d-204
PolandDrugs containing this active substance
-
This vaccine provides protection against yellow fever, a severe infectious disease transmitted by the bites of infected mosquitoes. It is used in individuals traveling to countries where the disease is present, in persons requiring an international certificate of vaccination, and in workers exposed to infectious material.
Form: powder and solvent for preparation of suspension for injection
Active substance Dosage live attenuated yellow fever virus strain 17d-204 not less than 1000 LD50 ATC: J07BL01
Manufacturer: Sanofi Winthrop Industrie